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Background:  Cocaine  abuse  is  capable  of activating  the  innate  immune  system  in  the  CNS  resulting  in
deregulation  of  homeostasis  between  pro  and  antiinﬂammatory  cytokines.  The  aim  of  this  study  was  to
investigate  serum  levels  of  pro  and  antiinﬂammatory  cytokines,  IL-6 and  IL-10  respectively,  in cocaine
users  from  a  young  population-based  sample.
Methods:  This  is a case–control  study  nested  in a cross-sectional  population-based  survey,  with  individ-
uals  of  18  and  35 years  old.  Two  groups  were  selected:  24  healthy  controls  and  12  subjects  who  reported
cocaine  use.  Serum  IL-6  and  IL-10 were  measured  by  ELISA  using  a commercial  kit.
Results:  There  was  a  statistically  signiﬁcant  increase  in  IL-6  (p = 0.037)  and  decrease  in  IL-10  (p  =  0.007)
serum  levels,  between  cocaine  users  and  the control  group.  There  was  also  an  increase  in  the ratio  IL-L-6
L-10
6/IL-10  (p =  0.013)  among  cocaine  users  individuals,  when  compared  to  the  control  group.
Conclusions:  Our  results  suggest  that  cocaine  users  showed  an  activation  of  the  immune  system  when
compared  a control  group,  demonstrating  a disruption  in  the  balance  of  pro  and  antiinﬂammatory
cytokines.  Thus,  peripheral  cytokines  may  represent  a putative  biomarkers  for cocaine  users,  contributing
to the development  of diagnosis  and  effective  treatments.. Introduction
Cocaine abuse is an important public health problem, with
 high prevalence in young adults. In 2010, cocaine use on a
lobal level in the population between 15 and 64 years old was
.3–0.5% (UNODC, 2014). Psychostimulant use in general, includ-
ng cocaine, has been associated with behavioral and cognitive
lterations, such as impaired decision making, negative social,
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ﬁnancial, psychological and physical consequences (Goldstein et al.,
2007; Kalivas and Volkow, 2005; Porter et al., 2011). Recent stud-
ies have suggested that the chronic and acute use of cocaine
is able to activate speciﬁc innate immune response components
(Yamamoto et al., 2010), which include alterations in the cellu-
lar homeostasis of the liver, heart and brain, leading to cellular
toxicity processes (Hanisch and Kettenmann, 2007; Narvaez et al.,
2013; Streit, 2010). Regarding this cellular damage, several stud-
ies there demonstrated that cocaine promotes oxidative stress in
these organs, increasing the production of reactive oxygen species
(ROS; Hermida-Ameijeiras et al., 2004; Smythies and Galzigna,
1998). In the brain, the cocaine oxidative stress-induced inﬂam-
mation stimulates the hypothalamus–pituitary–adrenal (HPA) axis,
changing the levels of cytokines (Narvaez et al., 2013; Rivest,
2001).
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Cytokines have the function of stimulating cellular immune
esponse and play a fundamental role in the control and modulation
f local and systemic inﬂammatory responses, causing a con-
tant balance between proinﬂammatory and anti-inﬂammatory
ytokines (Bromander et al., 2012). Interleukin-6 (IL-6) is the main
roinﬂammatory cytokine activated in the innate immune pro-
ess, resulting in microglial activation (Porrino and Lyons, 2000).
n turn, Interleukin-10 (IL-10) is known as a factor that inhibits
he cytokine’s synthesis, thus being one of the most important
ndogenous anti-inﬂammatory agents produced by the organism
Bromander et al., 2012; Fox et al., 2012).
Assessing different peripheral biomarkers in cocaine users, like
nﬂammatory cytokines, can be relevant for a better understanding
f the pathophysiological burdens associated with this drug use.
here are few studies concerning the effects of cocaine use and
he possible changes in the immune system in a population-based
ample. Clinical and pre-clinical studies have shown that the use
f cocaine incurs in the increase of proinﬂammatory cytokines and
ecrease of anti-inﬂammatory ones (Piechota et al., 2010). The aim
f the present study is to evaluate the serum levels of proinﬂam-
atory cytokines, IL-6, and anti-inﬂammatory, IL-10, in cocaine
sers from a young population-based sample.
. Methods
This is a case-control study nested in a population-based one, of people aged
8–35, involving 2348 participants living in the city of Pelotas, (Brasil), between
une,  2011 and October, 2012. Sample selection was  performed by clusters, consid-
ring the census division of the city (Pelotas) in 2010 (IBGE—InstitutoBrasileiro de
eograﬁa e Estatística; http://www.ibge.gov.br).
After identifying the subjects, they were invited to participate in the study and
igned the informed consent form. This study was approved by the committee of
thics in research from the Catholic University of Pelotas (UCPEL), under Protocol
umber 15/2010.
Sociodemographic issues and psychoactive substance use data were collected
hrough a self-administered questionnaire. To evaluate alcohol use disorder, the
articipants also answered the CAGE questionnaire (Buchsbaum et al., 1992). Socio-
conomic evaluation was carried out using the IEN criteria (National Economic
ndex—ÍndiceEconômico Nacional), which is based on the accumulation of material
ssets and on the schooling of the head of the household. These criteria generate a
ontinuous variable which was presented in tertiles (Barros and Victora, 2005).
From the interview, all individuals who reported cocaine use were selected
n  = 26 individuals). However, those individuals diagnosed with mood disorder, or
ho  used alcohol concomitantly, were excluded from the sample (n = 14 individ-
als), totaling 12 individuals. From these, 24 other individuals who  reported no use
f  licit and illicit substances and no psychiatric disorder were matched by sex and
ge,  constituting a control group.
For the biochemical analysis, 10 mL  of blood were withdrawn from each subject
fter the interview by means of venipuncture into an anticoagulant-free vacuum
ube, between 8:00 and 11:00 am.  The blood was immediately centrifuged at
able 1
ocio-demographic and clinical characteristics of the sample according with cocaine use.
Total sample 
Gendera
Female 9 (25.0)
Male  27 (75.0) 
Ethnicitya
Caucasian 27 (75.0) 
No  caucasian 9 (25.0) 
Age  (years) b 25.83 ± 4.59 
Years  of studyb 12.25 ± 3.04 
Brazilian Economic Indexa
1  (minor) 12 (33.3) 
2  (intermediate) 12 (33.3) 
3  (highest) 12 (33.3) 
Cannabis usea,c
Yes 8 (22.2) 
No  28 (77.8) 
Total 36 (100.0) 
a 2 test, displayed as n (%).
b Student t test, displayed as mean ± standard deviation.
c Our controls are healthy and did not cannabis use.ependence 158 (2016) 181–185
4000 × g for 10 min, and serum was  kept frozen at −80 ◦C until analysis. Serum
IL-6 and IL-10 levels were measured using a commercial immunoassay kit (DuoSet
ELISA Development, R&D Systems, Inc., USA). Serum IL-6 and IL-10 levels were
expressed in pg/mL.
Statistical analysis was performed with the Statistical Program for Social Sci-
ences (SPSS) 21.0 and Graph Pad Prism 6.0. Serum IL-6 and IL-10 levels had
non-Gaussian distributions. For nonparametric data, we utilized the Mann–Whitney
test, the Spearman correlation test, and the Kruskal–Wallis. Serum cytokines levels
were presented as median and interquartile range. A linear regression analysis was
applied to control for possible confounding factors with a p value ≤0.2 in the bivari-
ate analysis. Results with p values ≤0.05 were considered statistically signiﬁcant.
3. Results
Among the 36 analyzed subjects, 12 (33.3%) cocaine users and
8 (22.2%) cannabis sativa users were identiﬁed. Table 1 shows
socio-demographic characteristics of the subjects according to
cocaine use. Our results reveal no difference between control and
the cocaine users groups for sociodemographic characteristics.
However, among cocaine users, 8 (66.7%) subjects are cannabis
users, and show a signiﬁcant difference between the cocaine and
control groups (p ≤ 0.001; Table 1). Table 2 shows the serum
cytokines levels (IL-6, IL-10) and socio-demographic characteris-
tics and cannabis sativa users, between cocaine users and controls
groups.
There was a statistically signiﬁcant difference between cocaine
users and the control group IL-6 (p = 0.037) and IL-10 (p = 0.007)
serum levels. IL-6 levels were higher in the cocaine users group with
a median of 19.35 (13.37–34.57) pg/mL in relation to the control
group with a median of 13.13 (12.05–15.88) pg/mL, while the levels
of IL-10 were lower in the cocaine users group, where the median
was 40.37 (33.56–57.50) pg/mL in relation to the control group with
a median of 56.68 (48.09–92.23) pg/mL (Fig. 1).
In order to evaluate the inﬂuence of possible confounding fac-
tors interfering in the results, we  performed an adjusted analysis
according to gender, socio-economic index and cannabis use for
serum cytokines levels and the results remained signiﬁcant (IL-6:
p = 0.039; IL-10: p = 0.045).
For verifying, the relationship between the pro-inﬂammatory
cytokines (IL-6) with the anti-inﬂammatory cytokines (IL-10) was
made as a ratio of these cytokines levels for each subject. There was
a statistically signiﬁcant difference between the two groups in IL-
6/IL-10 (p = 0.013). The median ratios were 0.22 (0.15–0.31) in the
control group and 0.53 (0.32–0.98) in cocaine user to IL-6/IL-10.
After adjustment for potential confounders, both ratios remained
statistically signiﬁcant (IL-6/IL-10: p ≤ 0.001; Fig. 1).
Controls Cocaine users p Value
6 (25.0) 3 (25.0) 1.000
18 (75.0) 9 (75.0)
19 (79.2) 8 (66.7) 0.414
5 (20.8) 4 (33.3)
26.29 ± 4.52 24.92 ± 4.80 0.405
12.92 ± 2.31 10.92 ± 3.92 0.302
0.325
9 (37.5) 3 (25.0)
6 (25.0) 6 (50.0)
9 (37.5) 3 (25.0)
0 (0.0) 8 (66.7) 0.001
24 (100.0) 4 (33.3)
24 (66.7%) 12 (33.3%)
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Table  2
Socio-demographic and clinical characteristics of the sample according to serum levels of IL-6 and IL-10.
Cocaine Users (n = 12) Controls (n = 24)
IL-6 level
(pg/mL)
IL-10 level
(pg/mL)
IL-6 level
(pg/mL)
IL-10 level
(pg/mL)
Gendera p = 0.182 p = 0.182 p = 1.00 p = 0.640
Female 36.07
(29.83–40.03)
59.80
(55.20–66.34)
13.73
(8.07–14.79)
62.81
(53.04–112.29)
Male 17.15
(13.11–20.10)
37.63
(33.23–41.51)
13.05
(12.12–20.84)
55.13
(43.39–85.06)
Ethnicitya 0.545 0.545 1.00 0.317
Caucasian 16.37
(11.58–27.56)
36.87
(22.23–55.23)
12.87
(9.17–15.56)
55. 89
(43.72–96.23)
No  caucasian 13.78
(11.07–21.25)
46.66
(38.91–67.31)
14.54
(13.73–27.65)
65.78
(51.11–83.94)
Age (years)b p = 0.486
r  = 0.234
p = 0.827
r  = −0.067
p = 0.241
r  = −0.249
p = 0.316
r = 0.214
Years  of studyb p = 0.837
r  = −0.064
p = 0.671
r  = −0.137
p = 0.837
r  = −0.067
p = 0.689
r = −0.089
Brazilian Economic Indexc p = 0.513 p = 0.534 p = 0.411 p = 0.062
1  (minor) 36.07
(23.26–40.06)
42.71
(42.12–51.26)
14.54
(13.13–27.65)
68.30
(40.21–102.67)
2 (intermediate) 16.37
(13.11–23.58)
36.87
(33.23–50.61)
13.13
(12.69–14.69)
55.43
(48.54–73.39)
3 (highest) 20.10
(18.62–32.04)
37.64
(24.65–55.25)
9.17
(8.25–16.16)
54.37
(48.68–92.35)
Cannabis usea,d p = 0.654 p = 0.545 – –
Yes  19.35
(11.58–28.43)
36. 87
(22.24–48.34)
– –
No  26.61
(14.89–42.04)
51.26
(38.90–67.74)
13.13
(12.04–15.88)
56.68
(48.09–92.23)
Total 19.35
(13.36–34.56)
40.37
(33.55–57.50)
13.13
(12.05–15.88)
56.68
(48.09–92.23)
a Mann–Whitney test.
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cb Spearman correlation test.
c Kruskal–Wallis.
d Our controls are healthy and did not cannabis use.
. Discussion
The present study evaluated the serum interleukins levels in
oung subjects related to cocaine use. These subjects showed
igher serum IL-6 levels and lower serum IL-10 levels, when
ompared to subjects without reported cocaine use. Moreover, to
valuate the balance between Th1 and Th2 response, the IL-6/IL-
0 ratio was evaluated and this parameter presented increased in
ocaine users. Thus, these results pointed to an inﬂammatory status
ssociated to cocaine use.
Cocaine use, it has been described, can interfere in the pro-
uction and release of cytokines, demonstrating its role on
mmunomodulatory capacity and infection (Mao  et al., 1996).
sychostimulant abuse is associated with exaggerated innate
mmune response activation in CNS (Narvaez et al., 2013; Wisor
t al., 2011). This substance exposure results in the increase of
ig. 1. (A) The serum levels of pro-inﬂammatory cytokines (IL-6) were increased in cocai
3.13 (12.05–15.88) pg/mL; respectively p = 0.037). (B) The serum levels of antiinﬂammat
edian: 40.37 (33.56–57.50) pg/mL; median 56.68 (48.09–92.23) pg/mL; respectively p
ontrol  group median: 0.53 (0.32–0.98); median: 0.22 (0.15–0.31); respectively p = 0.013)pro-inﬂammatory citokynes in various regions of the brain (Chen
et al., 2008). In this sense, Wisor et al. (2011) showed that
microglial activation, in response to psychostimulants increased
pro-inﬂammatory cytokines, including IL-6. In this case, there
is a cellular response that will lead to exaggerated production
of proinﬂammatory cytokines (Benito et al., 2008). Therefore, cir-
culating cytokines can cross the blood brain barrier, and central
changes will reﬂect in peripheral circulation (Ghosh et al., 2014).
A study performed by Ersche et al. (2014), found increased sali-
vary levels of IL-6 in cocaine-dependent men when compared to
the control group, which had no personal or family history of sub-
stance use disorders. Moreover, he did not ﬁnd a difference in
salivary levels of IL-10 between the groups (Ersche et al., 2014).
Our present study evaluated the pro-inﬂammatory cytokine IL-6
and found increased levels of this cytokine in individuals who used
cocaine. In the study, we suggested that this increase in the cocaine
ne users when compared to controls. Median: 19.35 (13.37–34.57) pg/mL; median:
ory cytokines (IL-10) were decreased in cocaine users when compared to controls.
 = 0.007). (C) IL-6/IL-10 ratio were increased in cocaine users when compared to
.
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sers may  be indicative of neuronal damage, once we found similar
esults with the literature.
Chronic and acute psychostimulants exposure is related to an
ctivation of speciﬁc components of the innate immune response
Yamamoto et al., 2010), thus altering the homeostasis in the CNS
eading to toxicity damage (Hanisch and Kettenmann, 2007; Mao
t al., 1996). Cocaine users will present an exaggerated neuroin-
ammatory state, and thus, this process will promote a decrease
n circulating levels of IL-10. Previous studies have shown that
L-10 was induced by pro-inﬂammatory cytokines, and that IL-
0 diminished the cytokine response (Taniguchi et al., 1999). This
iminished cytokine response is relevant for the inhibition of the
ynthesis of proinﬂammatory cytokines; the decrease in serum
evels of IL-10 will stimulate the local inﬂammatory process and
ncrease the cell damage (Fox et al., 2012; Gan et al., 1998).
Chronic cocaine use is associated to the development of co-
orbidities, such as affective disorders, reinforcing negative main-
enance and relapse effects of drug abuse (Araos et al., 2014; Chahua
t al., 2015; Fox et al., 2012). Fox et al. (2012) evaluated the serum
evels TNF-, IL-10 and IL-1 in cocaine dependents (without any
ental disorder or dependence on any other illegal drug or alcohol)
nd social drinker patients, used as a control group. Cocaine-
ependent individuals demonstrated reduced plasmatic levels of
L-10 compared to social drinkers (Fox et al., 2012). Our results are
n accordance to this study; we found the decrease in the serum
evels of IL-10 in individuals who used cocaine compared to those
n the healthy controls, emphasizing the importance of cytokines
s a neuromodulatory role in the abuse of psychostimulants.
In a study by Narvaez et al. (2013), an increase in pro-
nﬂammatory cytokines IL-1 and TNF- was observed in crack
busers. It is important to note that crack is the cocaine in its free
ase form (Narvaez et al., 2013). Ersche et al. (2014) found increased
alivary levels of IL-6 in cocaine-dependent men  when compared
o the control group, which has no personal or family history of
ubstance use disorders. Moreover, he did not ﬁnd difference in
alivary levels of IL-10 between the groups (Ersche et al., 2014).
ur present study evaluated the pro-inﬂammatory cytokine IL-6
nd found increased levels of this cytokine in individuals who  used
ocaine. The use of psychostimulant substances, such as cocaine
nd crack, can be associated with cellular damage, since the pro-
nﬂammatory cytokines are increased.
Regarding inﬂammatory events, excessive immune activa-
ion is considered a key process for cellular damage, leading
o toxic responses, such as an increased secretion of cytokines
ith pro-inﬂammatory activity (IL-6). When there is an exces-
ive disturbance of the immune system, there is a disruption in
he balance of cytokines, which leads to the anti-inﬂammatory
nterleukins being unable to control the increased production
f pro-inﬂammatory interleukins. Moreover, several studies have
hown that as IL-6/IL-10 ratio is an indicative between TH1/TH2
alance (Sousa et al., 2015).
It is known that cocaine is able to induce the inﬂammatory
ytokines release both in the peripheral organs and central ner-
ous system, and this inﬂammatory status is presented in cocaine
sers as well the immunity in these subjects is compromised (Maes,
008; Maes et al., 2009). In this paper, we postulate that users from
 population sample have a decrease in immunity, and this sub-
tance abuse will reﬂect in a possible damage in several systems
unctions, including in the brain. Part of this hypothesis is based on
he increase of serum inﬂammatory cytokines reaching the brain,
rossing the blood-brain-barrier and leading to an increase of these
ytokines in the cerebrospinal ﬂuid (Miller et al., 2013; Rosenblat
t al., 2015, 2014). In addition, the presence of functional lym-
hatic vessels lining the dural sinuses (Louveau et al., 2015) and the
icroglia activation in cocaine users (Little et al., 2009) are worth
oting.ependence 158 (2016) 181–185
Limitations of our study include the lack of a control over quan-
tity or time of cocaine use and a small sample size. However, in
our study, the users are young individuals without medication use
and identiﬁed from a population-based study. Most other studies
utilize users admitted to psychiatric and psychological clinics,
usually due to abuses of substances which may interfere with the
inﬂammatory parameters. It is also important to note that in our
study cocaine users had no psychiatric disorder and also did not
use alcohol. Some of the individuals reported concomitant use of
cannabis and tobacco, which is common among cocaine users, but
did not interfere in the statistical analysis, therefore indicating that
the results are reﬂecting the change caused by the use of cocaine.
In conclusion, this study demonstrates that cocaine users
showed increased serum levels of IL-6 and decreased levels of IL-10
when compared to healthy subjects. These results suggest an acti-
vation of the immune system and consequent neuronal damage.
Thus, peripheral cytokines may represent a putative biomarkers
for cocaine users, contributing to the development of diagnosis
and effective treatments. However, future studies are needed to
elucidate the immune mechanism in cocaine users.
Conﬂict of interest
The authors declare that there is no conﬂict of interest.
References
Araos, P., Pedraz, M., Serrano, A., Lucena, M.,  Barrios, V., Garcia-Marchena, N.,
Campos-Cloute, R., Ruiz, J.J., Romero, P., Suarez, J., Baixeras, E., de la Torre, R.,
Montesinos, J., Guerri, C., Rodriguez-Arias, M.,  Minarro, J., Martinez-Riera, R.,
Torrens, M.,  Chowen, J.A., Argente, J., Mason, B.J., Pavon, F.J., Rodriguez de
Fonseca, F., 2014. Plasma proﬁle of pro-inﬂammatory cytokines and
chemokines in cocaine users under outpatient treatment: inﬂuence of cocaine
symptom severity and psychiatric co-morbidity. Addict. Biol.
Barros, A., Victora, C., 2005. A nationwide wealth score based on the 2000 Brazilian
demographic census. Rev. Saúde Pública 39, 523–529.
Benito, C., Tolon, R.M., Pazos, M.R., Nunez, E., Castillo, A.I., Romero, J., 2008.
Cannabinoid CB2 receptors in human brain inﬂammation. Br. J. Pharmacol. 153
(2),  277–285.
Bromander, S., Anckarsater, R., Kristiansson, M.,  Blennow, K., Zetterberg, H.,
Anckarsater, H., Wass, C.E., 2012. Changes in serum and cerebrospinal ﬂuid
cytokines in response to non-neurological surgery: an observational study. J.
Neuroinﬂamm. 9, 242.
Buchsbaum, D.G., Buchanan, R.G., Welsh, J., Centor, R.M., Schnoll, S.H., 1992.
Screening for drinking disorders in the elderly using the CAGE questionnaire. J.
Am.  Geriatr. Soc. 40 (7), 662–665.
Chahua, M., Sanchez-Niubo, A., Torrens, M.,  Sordo, L., Bravo, M.J., Brugal, M.T.,
Domingo-Salvany, A., 2015. Quality of life in a community sample of young
cocaine and/or heroin users: the role of mental disorders. Qual. Life Res.
Chen, B.T., Bowers, M.S., Martin, M.,  Hopf, F.W., Guillory, A.M., Carelli, R.M., Chou,
J.K.,  Bonci, A., 2008. Cocaine but not natural reward self-administration nor
passive cocaine infusion produces persistent LTP in the VTA. Neuron 59 (2),
288–297.
Ersche, K.D., Hagan, C.C., Smith, D.G., Abbott, S., Jones, P.S., Apergis-Schoute, A.M.,
Dofﬁnger, R., 2014. Aberrant disgust responses and immune reactivity in
cocaine-dependent men. Biol. Psychiatry 75 (2), 140–147.
Fox, H.C., D’Sa, C., Kimmerling, A., Siedlarz, K.M., Tuit, K.L., Stowe, R., Sinha, R., 2012.
Immune system inﬂammation in cocaine dependent individuals: implications
for  medications development. Hum. Psychopharmacol. 27 (2), 156–166.
Gan, X., Zhang, L., Newton, T., Chang, S.L., Ling, W.,  Kermani, V., Berger, O., Graves,
M.C., Fiala, M.,  1998. Cocaine infusion increases interferon-gamma and
decreases interleukin-10 in cocaine-dependent subjects. Clin. Immunol.
Immunopathol. 89 (2), 181–190.
Ghosh, A., Birngruber, T., Sattler, W.,  Kroath, T., Ratzer, M.,  Sinner, F., Pieber, T.R.,
2014. Assessment of blood–brain barrier function and the neuroinﬂammatory
response in the rat brain by using cerebral open ﬂow microperfusion (cOFM).
PLOS ONE 9 (5), e98143.
Goldstein, R.Z., Alia-Klein, N., Tomasi, D., Zhang, L., Cottone, L.A., Maloney, T.,
Telang, F., Caparelli, E.C., Chang, L., Ernst, T., Samaras, D., Squires, N.K., Volkow,
N.D., 2007. Is decreased prefrontal cortical sensitivity to monetary reward
associated with impaired motivation and self-control in cocaine addiction?
Am.  J. Psychiatry 164 (1), 43–51.
Hanisch, U.K., Kettenmann, H., 2007. Microglia: active sensor and versatile effector
cells in the normal and pathologic brain. Nat. Neurosci. 10 (11), 1387–1394.
Hermida-Ameijeiras, A., Mendez-Alvarez, E., Sanchez-Iglesias, S.,
Sanmartin-Suarez, C., Soto-Otero, R., 2004. Autoxidation and MAO-mediated
metabolism of dopamine as a potential cause of oxidative stress: role of
ferrous and ferric ions. Neurochem. Int. 45 (1), 103–116.
ohol D
K
L
L
M
M
M
M
N
P
P
Wisor, J.P., Schmidt, M.A., Clegern, W.C., 2011. Cerebral microglia mediateF.P. Moreira et al. / Drug and Alc
alivas, P.W., Volkow, N.D., 2005. The neural basis of addiction: a pathology of
motivation and choice. Am.  J. Psychiatry 162 (8), 1403–1413.
ittle, K.Y., Ramssen, E., Welchko, R., Volberg, V., Roland, C.J., Cassin, B., 2009.
Decreased brain dopamine cell numbers in human cocaine users. Psychiatry
Res. 168 (3), 173–180.
ouveau, A., Smirnov, I., Keyes, T.J., Eccles, J.D., Rouhani, S.J., Peske, J.D., Derecki,
N.C.,  Castle, D., Mandell, J.W., Lee, K.S., Harris, T.H., Kipnis, J., 2015. Structural
and  functional features of central nervous system lymphatic vessels. Nature
523 (7560), 337–341.
aes, M.,  2008. The cytokine hypothesis of depression: inﬂammation, oxidative &
nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive
treatments in depression. Neuro Endocrinol. Lett. 29 (3), 287–291.
aes, M.,  Yirmyia, R., Noraberg, J., Brene, S., Hibbeln, J., Perini, G., Kubera, M.,  Bob,
P.,  Lerer, B., Maj, M.,  2009. The inﬂammatory & neurodegenerative (I&ND)
hypothesis of depression: leads for future research and new drug
developments in depression. Metab. Brain Dis. 24 (1), 27–53.
ao, J.T., Huang, M.,  Wang, J., Sharma, S., Tashkin, D.P., Dubinett, S.M., 1996.
Cocaine down-regulates IL-2-induced peripheral blood lymphocyte IL-8 and
IFN-gamma production. Cell Immunol. 172 (2), 217–223.
iller, A.H., Haroon, E., Raison, C.L., Felger, J.C., 2013. Cytokine targets in the brain:
impact on neurotransmitters and neurocircuits. Depress. Anxiety 30 (4),
297–306.
arvaez, J.C., Magalhaes, P.V., Fries, G.R., Colpo, G.D., Czepielewski, L.S., Vianna, P.,
Chies, J.A., Rosa, A.R., Von Diemen, L., Vieta, E., Pechansky, F., Kapczinski, F.,
2013. Peripheral toxicity in crack cocaine use disorders. Neurosci. Lett. 544,
80–84.
iechota, M.,  Korostynski, M.,  Solecki, W.,  Gieryk, A., Slezak, M., Bilecki, W.,
Ziolkowska, B., Kostrzewa, E., Cymerman, I., Swiech, L., Jaworski, J., Przewlocki,
R.,  2010. The dissection of transcriptional modules regulated by various drugs
of  abuse in the mouse striatum. Genome Biol. 11 (5), R48.
orrino, L.J., Lyons, D., 2000. Orbital and medial prefrontal cortex and
psychostimulant abuse: studies in animal models. Cereb. Cortex 10 (3),
326–333.ependence 158 (2016) 181–185 185
Porter, J.N., Olsen, A.S., Gurnsey, K., Dugan, B.P., Jedema, H.P., Bradberry, C.W.,
2011. Chronic cocaine self-administration in rhesus monkeys: impact on
associative learning, cognitive control, and working memory. J. Neurosci. 31
(13), 4926–4934.
Rivest, S., 2001. How circulating cytokines trigger the neural circuits that control
the hypothalamic–pituitary–adrenal axis. Psychoneuroendocrinology 26 (8),
761–788.
Rosenblat, J.D., Brietzke, E., Mansur, R.B., Maruschak, N.A., Lee, Y., McIntyre, R.S.,
2015. Inﬂammation as a neurobiological substrate of cognitive impairment in
bipolar disorder: evidence, pathophysiology and treatment implications. J.
Affect. Disord. 188, 149–159.
Rosenblat, J.D., Cha, D.S., Mansur, R.B., McIntyre, R.S., 2014. Inﬂamed moods: a
review of the interactions between inﬂammation and mood disorders. Prog.
Neuropsychopharmacol. Biol. Psychiatry 53, 23–34.
Smythies, J., Galzigna, L., 1998. The oxidative metabolism of catecholamines in the
brain: a review. Biochim. Biophys. Acta 1380 (2), 159–162.
Sousa, A., Raposo, F., Fonseca, S., Valente, L., Duarte, F., Goncalves, M.,  Tuna, D.,
Paiva, J.A., 2015. Measurement of cytokines and adhesion molecules in the ﬁrst
72 hours after severe trauma: association with severity and outcome. Dis.
Markers 2015, 747036.
Streit, W.J., 2010. Microglial activation and neuroinﬂammation in Alzheimer’s
disease: a critical examination of recent history. Front. Aging Neurosci. 2, 22.
Taniguchi, T., Koido, Y., Aiboshi, J., Yamashita, T., Suzaki, S., Kurokawa, A., 1999. The
ratio of interleukin-6 to interleukin-10 correlates with severity in patients
with chest and abdominal trauma. Am.  J. Emerg. Med. 17 (6), 548–551.
UNODC, 2014. United Nations Ofﬁce on Drugs and Crime. World Drug Report.
UNODC, New York.sleep/wake and neuroinﬂammatory effects of methamphetamine. Brain Behav.
Immun. 25 (4), 767–776.
Yamamoto, B.K., Moszczynska, A., Gudelsky, G.A., 2010. Amphetamine toxicities:
classical and emerging mechanisms. Ann. N. Y. Acad. Sci. 1187, 101–121.
